Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

被引:0
|
作者
Huselton, Eric
Slade, Michael
Abboud, Camille
Cashen, Amanda
DiPersio, John F.
Ghobadi, Armin
Pusic, Iskra
Romee, Rizwan
Uy, Geoffrey L.
Vij, Ravi
Westervelt, Peter
Schroeder, Mark A.
机构
关键词
D O I
10.1016/j.bbmt.2016.12.185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
380
引用
收藏
页码:S278 / S278
页数:1
相关论文
共 50 条
  • [1] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    [J]. BLOOD, 2012, 120 (21)
  • [2] Second malignancies after allogeneic hematopoietic cell transplantation
    Lowe, Thomas
    Bhatia, Smita
    Somlo, George
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) : 1121 - 1134
  • [3] Second Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies for Relapse After First Allografts
    Gyurkocza, Boglarka
    Storb, Rainer
    Chauncey, Thomas
    Maloney, David G.
    Storer, Barry
    Sandmaier, Brenda M.
    [J]. BLOOD, 2012, 120 (21)
  • [4] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
    Shah, Nirali
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather
    Loeb, David
    Wayne, Alan S.
    Chen, Allen
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S306 - S306
  • [5] Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies
    Eapen, Mary
    O'Donnell, Paul
    Brunstein, Claudio G.
    Wu, Juan
    Barowski, Kate
    Mendizabal, Adam
    Fuchs, Ephraim J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1485 - 1492
  • [6] Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
    Mielcarek, Marco
    Storer, Barry E.
    Flowers, Mary E. D.
    Storb, Rainer
    Sandmaier, Brenda M.
    Martin, Paul J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) : 1160 - 1168
  • [7] Adoptive Immunotherapies After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
    Xiong, Yu
    Bensoussan, Daniele
    Decot, Veronique
    [J]. TRANSFUSION MEDICINE REVIEWS, 2015, 29 (04) : 259 - 267
  • [8] Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
    Olsson, R. F.
    Logan, B. R.
    Chaudhury, S.
    Zhu, X.
    Akpek, G.
    Bolwell, B. J.
    Bredeson, C. N.
    Dvorak, C. C.
    Gupta, V.
    Ho, V. T.
    Lazarus, H. M.
    Marks, D. I.
    Ringden, O. T. H.
    Pasquini, M. C.
    Schriber, J. R.
    Cooke, K. R.
    [J]. LEUKEMIA, 2015, 29 (08) : 1754 - 1762
  • [9] Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies
    R F Olsson
    B R Logan
    S Chaudhury
    X Zhu
    G Akpek
    B J Bolwell
    C N Bredeson
    C C Dvorak
    V Gupta
    V T Ho
    H M Lazarus
    D I Marks
    O T H Ringdén
    M C Pasquini
    J R Schriber
    K R Cooke
    [J]. Leukemia, 2015, 29 : 1754 - 1762
  • [10] The use of second allogeneic hematopoietic stem cell transplantation for hematologic malignancies relapsed after the first: Does it worth to do?
    Goksoy, Hasan Sami
    Arat, Mutlu
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 91 - 98